Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
205 studies found for:    Open Studies | "Hepatitis B"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hepatitis B"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Hepatitis B Research Network Pediatric Cohort Study (HBRN)
Condition: Hepatitis B
Intervention:
2 Recruiting Hepatitis B Research Network Adult Cohort Study
Condition: Hepatitis B
Intervention:
3 Recruiting "Real-life" Cohort of Patients With Chronic Hepatitis B Virus Infection
Condition: Hepatitis B
Intervention:
4 Not yet recruiting Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus
Condition: Hepatitis B
Intervention: Drug: Tenofovir Disoproxil Fumarate
5 Recruiting A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B
Condition: Chronic Hepatitis B
Intervention:
6 Recruiting Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogues
Condition: Chronic Hepatitis B
Interventions: Drug: Continue NA treatment;   Drug: Discontinue NA Treatment
7 Recruiting The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Drug: Metacavir Enteric-coated Capsules 80mg;   Drug: Metacavir Enteric-coated Capsules 160mg;   Drug: Metacavir Enteric-coated Capsules 320mg;   Drug: Metacavir Enteric-coated Capsules Placebo 240mg;   Drug: Metacavir Enteric-coated Capsules Placebo 160mg;   Drug: Metacavir Enteric-coated Capsules Placebo 320mg;   Drug: Adefovir Dipivoxil Capsule10mg;   Drug: Adefovir Dipivoxil Capsule Placebo 10mg
8 Recruiting Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: Pegasys&Entecavir
9 Recruiting Mechanisms Associated With Favorable Responses to Peginterferon-Alpha Add-on Therapy Following Long-term Nucleos(t)Ide Analogue Treatment in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: Peginterferon alfa-2a
10 Recruiting Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b
Condition: Chronic Hepatitis b
Intervention: Drug: Entecavir or Tenofovir
11 Recruiting PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Drug: Peginterferon alfa-2a;   Drug: Nucleos(t)ide analogue
12 Recruiting Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma
Condition: Hepatitis B
Interventions: Drug: Entecavir prophylaxis;   Drug: Observation arm
13 Recruiting A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During Infancy
Condition: Hepatitis B
Intervention: Biological: Engerix™-B Kinder
14 Recruiting Is Hepatitis B Surface Antigen (HB s Ag) Enough Alone as a Screening Test Before Immunosuppressive Therapies?
Condition: Hepatitis B
Intervention: Other: HBV core antibodies testing. • Real time PCR testing.
15 Not yet recruiting TAF Switch Study in Hepatitis B Monoinfection
Condition: Hepatitis B
Intervention: Drug: Tenofovir alafenamide fumarate
16 Recruiting The Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus-drug Test
Condition: Hepatitis B Virus Infection, Pregnancy
Intervention: Drug: antiviral therapy
17 Recruiting Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B
Condition: Hepatitis B
Interventions: Biological: FP-02.2 Vaccine;   Other: Placebo;   Other: IC31® Adjuvant
18 Recruiting Prevalence of Hepatitis B in Vallés Occidental. Observational Multicentric Study
Condition: Hepatitis B
Intervention: Other: Not apply
19 Not yet recruiting Emtricitabine for Naive Chinese Chronic Hepatitis B Patients
Condition: Hepatitis B, Chronic
Intervention: Drug: Emtricitabine
20 Recruiting Efficay of Extended Peginterferon Alpha 2a Treatment in HBeAg Negative Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.